Skip to content


Javlor (vinflunine) is a small molecule pharmaceutical. Vinflunine was first approved as Javlor on 2009-09-21. It has been approved in Europe to treat transitional cell carcinoma and urologic neoplasms.
Trade Name Javlor
Common Name Vinflunine
Indication transitional cell carcinoma, urologic neoplasms
Drug Class Vinca alkaloids
Get full access now